Possible involvement of viral infection in the pathogenesis of myasthenia gravis.

Publication date: Aug 26, 2026

Myasthenia gravis (MG) is a chronic autoimmune disorder that involves the targeting of neuromuscular junctions and is primarily driven by autoantibodies against the acetylcholine receptor (AChR). While genetic susceptibility is a factor, environmental triggers, particularly viral infections, are being increasingly investigated as potential contributors to MG pathogenesis. This review examines the complex interplay between viral pathogens and MG, highlighting mechanisms such as molecular mimicry, bystander activation, and the aberrant stimulation of innate immune pathways via Toll-like receptors (TLRs). Key DNA viruses, including Epstein‒Barr virus (EBV) and parvovirus B19, have been detected within hyperplastic thymic tissues and thymomas, suggesting that they may sustain local autoreactive B-cell activation. Furthermore, recent clinical data emphasize the role of RNA viruses, most notably SARS-CoV-2, as significant triggers of new-onset MG and myasthenic crises. Despite substantial evidence linking viral infections to MG, further mechanistic research and large-scale observational studies are needed to definitively establish causality and refine therapeutic strategies targeting these virus-induced immune responses.

Concepts Keywords
Acetylcholine Animals
Environmental Autoantibodies
Genetic Autoantibodies
New Autoimmunity
Parvovirus B-Lymphocytes
COVID-19
Epstein-Barr Virus Infections
Herpesvirus 4, Human
Humans
Immunity, Innate
Molecular Mimicry
Myasthenia Gravis
Myasthenia gravis
Parvovirus B19, Human
Receptors, Cholinergic
Receptors, Cholinergic
SARS-CoV-2
Thymoma
Thymus
Thymus Gland
Toll-Like Receptors
Toll-Like Receptors
Viruses

Semantics

Type Source Name
disease MESH viral infection
disease MESH myasthenia gravis
drug DRUGBANK Acetylcholine
disease MESH genetic susceptibility
disease MESH thymomas
disease MESH COVID-19
disease MESH Epstein-Barr Virus Infections

Original Article

(Visited 5 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *